A novel antiangiogenic effect for telomerase-specific virotherapy through host immune system

Journal of Immunology

Volumn 182, Issue 3, 2009, Pages 1763-1769

  Ikeda, Yoshihiro ^a   Kojima, Toru ^a   Kuroda, Shinji ^a   Endo, Yoshikatsu ^a   Sakai, Ryo ^a   Hioki, Masayoshi ^a   Kishimoto, Hiroyuki ^a   Uno, Futoshi ^a   Kagawa, Shunsuke ^a,b   Watanabe, Yuichi ^c   Hashimoto, Yuuri ^c   Urata, Yasuo ^c   Tanaka, Noriaki ^a   Fujiwara, Toshiyoshi ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^c National Institute of Infectious Diseases   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; OBP 301; RECOMBINANT GAMMA INTERFERON; TELOMELYSIN; TELOMERASE; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL; CELL VIABILITY; COLON TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEMALE; GENE; GENE E1; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; MALIGNANT NEOPLASTIC DISEASE; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; VIROTHERAPY; VIRUS ATTENUATION; ADENOCARCINOMA; ADENOVIRUS; ADENOVIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; COLORECTAL TUMOR; ENZYMOLOGY; GENE VECTOR; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METHODOLOGY; MIXED LYMPHOCYTE CULTURE; MOUSE MUTANT; NUDE MOUSE; ONCOLYTIC VIROTHERAPY; PATHOLOGY; TUMOR CELL LINE; VIROLOGY;

ADENOCARCINOMA; ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENETIC VECTORS; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; MICE, NUDE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; ONCOLYTIC VIROTHERAPY; TELOMERASE;

EID: 63149129761     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.3.1763     Document Type: Article

References (26)

1. Folkman, J. 1985. Tumor angiogenesis. Adv. Cancer Res. 43: 175-203.
2. Ausprunk, D. H., and J. Folkman. 1977. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14: 53-65.
3. Fidler, I. J., and L. M. Ellis. 1994. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 85-88.
4. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27-31.
5. Hanahan, D., and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenesis switch during tumorgenesis. Cell 86: 353-364.
6. Nyberg, P., L. Xie, and R. Kalluri. 2005. Endogenous inhibitors of angiogenesis. Cancer Res. 65: 3967-3979.
7. de Visser, K. E., A. Eichten, and L. M. Coussens. 2006. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6: 24-37.
8. Lin, W. W., and M. Karin. 2007. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117: 1175-1183.
9. Kawashima, T., S. Kagawa, N. Kobayashi, Y. Shirakiya, T. Umeoka, F. Teraishi, M. Taki, S. Kyo, N. Tanaka, and T. Fujiwara. 2004. Telomerase-specific replication-selective virotherapy for human cancer. Clin. Cancer Res. 10: 285-292.
10. Taki, M., S. Kagawa, M. Nishizaki, H. Mizuguchi, T. Hayakawa, S. Kyo, K. Nagai, Y. Urata, N. Tanaka, and T. Fujiwara. 2005. Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD'). Oncogene 24: 3130-3140.
11. Umeoka, T., T. Kawashima, S. Kagawa, F. Teraishi, M. Taki, M. Nishizaki, S. Kyo, K. Nagai, Y. Urata, N. Tanaka, and T. Fujiwara. 2004. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene. Cancer Res. 64: 6259-6265.
12. Kishimoto, H., T. Kojima, Y. Watanabe, S. Kagawa, T. Fujiwara, F. Uno, F. Teraishi, S. Kyo, H. Mizuguchi, Y. Urata, et al. 2006. In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Nat. Med. 12: 1213-1219.
13. Endo, Y., R. Sakai, M. Ouchi, H. Onimatsu, M. Hioki, S. Kagawa, F. Uno, Y. Watanabe, Y. Urata, N. Tanaka, and T. Fujiwara. 2008. Virus-mediated oncolysis induces danger signal and stimulates cytotoxic-T-lymphocyte activity via proteasome activator upregulation. Oncogene 27: 2375-2381.
14. Tanaka, N. G., N. Sakamoto, K. Inoue, H. Korenaga, S. Kadoya, H. Ogawa, and Y. Osada. 1989. Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid. Cancer Res. 49: 6727-6730.
15. Pfeiffer, P., C. Qvortrup, and J. G. Eriksen. 2007. Current role of antibody therapy in patients with metastatic colorectal cancer. Oncogene 26: 3661-3678.
16. Bouvet, M., L. M. Ellis, M. Nishizaki, T. Fujiwara, W. Liu, C. D. Bucana, B. Fang, J. J. Lee, and J. A. Roth. 1998. Wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. 58: 2288-2292.
17. Nishizaki, M., T. Fujiwara, T. Tanida, A. Hizuta, H. Nishimori, T. Tokino, Y. Nakamura, M. Bouvet, J. A. Roth, and N. Tanaka. 1999. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect. Clin. Cancer Res. 5: 1015-1023.
18. Lindenmann, J., and P. A. Klein. 1967. Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus. J. Exp. Med. 126: 93-108.
19. Sinkovics, J. G. 1991. Viral oncolysates as human tumor vaccines. Int. Rev. Immunol. 7: 259-287.
20. Li, H., A. Dutuor, X. Fu, and X. Zhang. 2007. Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model. J. Gene Med. 9: 161-169.
21. Fathallah-Shaykh, H. M., L. J. Zhao, A. I. Kafrouni, G. M. Smith, and J. Forman. 2000. Gene transfer of IFN-γ into established brain tumors represses growth by antiangiogenesis. J. Immunol. 164: 217-222.
22. + T cells. Cancer Res. 63: 4095-4100.
23. Ho, L. J., J. J. Wang, M. F. Shaio, C. L. Kao, D. M. Chang, S. W. Han, and J. H. Lai. 2001. Infection of human dendritic cells by Dengue virus causes cell maturation and cytokine production. J. Immunol. 166: 1499-1506.
24. Horton, M. R., C. M. McKee, C. Bao, F. Liao, J. M. Farber, J. Hodge-DuFour, E. Pure, B. L. Oliver, T. M. Wright, and P. W. Noble. 1998. Hyaluronan fragments synergize with interferon-γ to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J. Biol. Chem. 273: 35088-35094.
25. Ikeda, H., L. J. Old, and R. D. Schreiber. 2002. The roles of IFN γ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 13: 95-109.
26. Folkman, J. 2002. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29: 15-18.